Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -147,722 | -107,139 | -72,277 | -34,836 | -155,127 |
| Depreciation Amortization | -655 | -536 | -440 | -255 | -575 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 529 |
| Accounts payable and accrued liabilities | -6,536 | -7,730 | -8,328 | -5,387 | 7,788 |
| Other Working Capital | -590 | -247 | -361 | -5,642 | 19,415 |
| Other Operating Activity | 27,519 | 22,725 | 18,468 | 10,490 | 9,801 |
| Operating Cash Flow | $-127,983 | $-92,927 | $-62,938 | $-35,629 | $-118,169 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -700 | -1,351 | -1,130 | -67 | -391 |
| Purchase Of Investment | -80,720 | -58,333 | -25,778 | -14,328 | -271,157 |
| Sale Of Investment | 258,858 | 199,384 | 126,371 | 59,137 | 406,189 |
| Investing Cash Flow | $177,437 | $139,700 | $99,464 | $44,742 | $134,641 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,236 | 443 | 290 | 31 | 685 |
| Financing Cash Flow | $3,236 | $443 | $290 | $31 | $685 |
| Beginning Cash Position | 54,948 | 54,948 | 54,948 | 54,948 | 37,790 |
| End Cash Position | 107,637 | 102,163 | 91,763 | 64,091 | 54,948 |
| Net Cash Flow | $52,689 | $47,216 | $36,816 | $9,144 | $17,157 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,983 | -92,927 | -62,938 | -35,629 | -118,169 |
| Capital Expenditure | -700 | -1,351 | -1,130 | -67 | -391 |
| Free Cash Flow | -128,684 | -94,278 | -64,068 | -35,697 | -118,560 |